Vir Biotechnology (VIR) Other financing activities (2019 - 2025)

Vir Biotechnology has disclosed Other financing activities across 5 years of filings, most recently posting -$2000.0 for Q4 2025.

• Other financing activities for Q4 2025 came in at -$2000.0, down 115.38% year-over-year; the trailing twelve-month figure through Dec 2025 was -$28000.0 (up 83.03% YoY), and the FY2025 annual result was -$361000.0, down 118.79% from the prior year.
• Other financing activities came in at -$2000.0 for Q4 2025 at Vir Biotechnology, down from $1000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $100000.0 in Q1 2023 to a low of -$387000.0 in Q4 2023.
• The 4-year median for Other financing activities is -$21000.0 (2024), against an average of -$89125.0.
• Across the five-year window, Other financing activities surged 103.36% in 2024 and sank 115.38% in 2025, its largest moves.
• Vir Biotechnology's Other financing activities stood at -$260000.0 in 2022, then slumped by 48.85% to -$387000.0 in 2023, then soared by 103.36% to $13000.0 in 2024, then tumbled by 115.38% to -$2000.0 in 2025.
• The last three Other financing activities figures came in at -$2000.0 (Q4 2025), $1000.0 (Q3 2025), and $13000.0 (Q4 2024), per Business Quant data.